Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease

Developmental Genetics

Volumn 24, Issue 3-4, 1999, Pages 309-318

  Gattone II, Vincent H ^a,b   Maser, Robin L ^a   Tian, Chunqiao ^a   Rosenberg, Joshua M ^a   Branden, Michael G ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Aquaporin; Development; Mouse; Polycystic kidney disease; Urine concentration; Vasopressin V2 receptor

Indexed keywords

ALDEHYDE REDUCTASE; AQUAPORIN; ARGIPRESSIN RECEPTOR; CYCLIC AMP; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; MOZAVAPTAN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CONTROLLED STUDY; GENE OVEREXPRESSION; KIDNEY COLLECTING TUBULE; KIDNEY CONCENTRATING CAPACITY; KIDNEY POLYCYSTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; UREMIA; URINE OSMOLALITY;

ALDEHYDE REDUCTASE; ANIMALS; AQUAPORIN 2; AQUAPORIN 3; AQUAPORIN 6; AQUAPORINS; BENZAZEPINES; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; KIDNEY CONCENTRATING ABILITY; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; POLYCYSTIC KIDNEY, AUTOSOMAL RECESSIVE; RECEPTORS, VASOPRESSIN; RNA, MESSENGER;

ANIMALIA; MAMMALIA; MURINAE; RODENTIA;

EID: 0032956538     PISSN: 0192253X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6408(1999)24:3/4<309::AID-DVG14>3.0.CO;2-5     Document Type: Article

References (39)

1. Aziz N, Brown D, Lee W-S, Naray-Fejes-Toth A. 1996. Aberrant 11β-hyroxysteroid dehydrogenase-1 activity in the cpk mouse: implications for the regulation by the Ke 6 gene. Endocrine 137:5581-5588.
2. Bichet DG, Oksche A, Rosenthal W. 1997. Congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 8:1951-1958.
3. Bonilla-Felix M, Jiang W. 1997. Aquaporin-2 in the immature rat: expression, regulation and trafficking. J Am Soc Nephrol 8:1502-1509.
4. Breyer MD, Jacobson HR, Breyer JA. 1988. Epidermal growth factor inhibits the hydroosmotic effect of vasopressin in the isolated perfused rabbit cortical collecting tubule. J Clin Invest 82:1313-1320.
5. Cowley BD, Gudapaty S, Kraybill AL, Barash BD, Harding MA, Calvet JP, Gattone VH. 1993. Autosomal dominant polycystic kidney disease in the rat. Kidney Int 43:522-534.
6. Cowley BD, Rupp JC, Muessel MJ, Gattone VH. 1997. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats. Am J Kidney Dis 29:265-272.
7. Echevarria M, Windhager EE, Tate SS, Frindt G. 1994. Cloning and expression of AQP3, a water channel from the medullary collecting duct of rat kidney. Proc Natl Acad Sci USA 91:10997-11001
8. Fushimi K, Uchida S, Kara Y, Hirata Y, Marumo F, Sasaki S. 1993. Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature 361:549-552.
9. Garcia-Perez A, Martin B, Murphy HR, Uchida S, Murer H, Cowley BD Jr, Handler JS, Burg MB. 1989. Molecular cloning of cDNA coding for kidney aldose reductase. Regulation of specific mRNA accumulation by NaCl-mediated osmotic stress. J Biol Chem 264: 16815-16821.
10. Gattone VH, Calvet JP, Cowley BD, Evan AP, Shaver TS, Helmstadter H, Grantham JJ. 1987. Autosomal recessive polycystic kidney disease in a murine model, a gross and microscopic description. Lab Invest 59:231-238.
11. Gattone VH, Andrews GK, Niu F, Chadwick LJ, Klein RM, Calvet JP. 1990. Defective epidermal growth factor gene expression in mice with polycystic kidney disease. Dev Biol 139:225-230.
12. Gattone VG, Lowden DA, Cowley BD. 1995a. Epidermal growth factor ameliorates autosomal recessive polycystic kidney disease in mice. Dev Biol 169:504-510.
13. Gattone VH, Schieren G, Killen PD. 1995b. Aberrant expression of extracellular matrix in infantile-type polycystic kidney disease in cpk/cpk mice (Abstract). J Am Soc Nephrol 6:694.
14. Gattone VH, Maser R, Branden M, Tian C, Rosenberg J. 1998. Collecting duct gene expression and effect of an AVP-V2 receptor antagonist on the progression of PKD in pcy mice (Abstract). J Am Soc Nephrol 9:18A.
15. Guay-Woodford LM. 1996. Autosomal recessive polycystic kidney disease: clinical and genetic profiles. In: Watson ML, Torres VE, editors. Polycystic kidney disease. Oxford: Oxford University Press. p 237-266.
16. Guay-Woodford LM, Muecher G, Hopkins SD, Avner ED, Germino GG, Guillot AP, Herrin J, Holleman R, Irons DA, Primack W et al. 1995. The severe perinatal form of autosomal recessive polycystic kidney disease maps to chromosome 6p21.1-p12: implications for genetic counseling. Am J Hum Genet 56:1101-1107.
17. Harding MA, Chadwick LJ, Gattone VH, Calvet JP. 1991. The SGP-2 gene is developmentally regulated in the mouse kidney and abnormally expressed in collecting duct cysts in polycystic kidney disease. Dev Biol 146:483-490.
18. Hayashi M, Yamaji Y, Monkawa T, Yoshida T, Tsuganezawa H, Sasamura H, Kitajima W, Sasaki S, Ishibashi K, Maurmo F, Saruta T. 1997. Expression and localization of the water channels in human autosomal dominant polycystic kidney disease. Nephron 75:321-326.
19. Horikoshi S, Kubota S, Martin GR, Yamada Y, Klotman PE. 1991. Epidermal growth factor (EGF) expression in the congenital polycystic mouse kidney. Kidney Int 39:57-62.
20. Knepper MA. 1997. Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin. Am J Physiol 272:F3-12.
21. Lee MD, King LS, Agre P. 1997. The aquaporin family of water channel proteins in clinical medicine. Medicine 76:141-156.
22. Lolait SJ, O'Carroll AM, McBride OW, Konig M, Morel A, Brownstein MJ. 1992. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357:336-339.
23. Ma T, Hasegawa H, Skach WR, Frigeri A, Verkman S. 1994. Expression, functional analysis, and in situ hybridization of a cloned rat collecting duct water channel. Am J Physiol 266:C189-C197.
24. Mangoo-Karim R, Uchic ME, Grant M, Shumate WA, Calvet JP, Park CH, Grantham JJ. 1989. Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP. FASEB J 3:2629-2632.
25. Maser RL, Magenheimer BS, Calvet JP. 1994. Mouse plasma glutathione peroxidase: cDNA sequence analysis and renal proximal tubular expression and secretion. J Biol Chem 269:27066-27073.
26. Phillips PA, Grant SL, Davidson AF, Risvanis J, Stephenson J, Gow CB. 1994. Epidermal growth factor antagonizes vasopressin in vivo and in vitro. Kidney Int 45:1028-1036.
27. Rankin CA, Grantham JJ, Calvet JP. 1992. C-fos expression is hypersensitive to serum-stimulation in cultured cystic kidney cells from the C57BL/6J-cpk mouse. J Cell Physiol 152:578-586.
28. Rankin CA, Suzuli K, Itoh Y, Ziemer DM, Grantham JJ, Calvet JP, Nagase H. 1996. Matrix metalloproteinases and TIMPs in cultured C57BL/6J-cpk kidney tubules. Kidney Int 50:835-844.
29. Rankin CA, Itoh Y, Tian C, Ziemer DM, Calvet JP, Gattone VH. 1999. Matrix metalloproteinase 2 in a murine model of infantile polycystic kidney disease. J Am Soc Nephrol 10:210-217.
30. Saito T, Ishiawa SE, Sasaki S, Fujita N, Fushimi K, Okada K, Takeuchi K, Sakamoto A, Ookawara S, Kaneko T, Marumo F, Saito T. 1997. Alteration in water channel AQP-2 by removal of AVP stimulation in collecting duct cells of dehydrated rats. Am J Physiol 272:F183-191.
31. Schwartz GJ, Zavilowitz BJ, Radice AD, Garcia Perez A, Sands JM. 1992. Maturation of aldose reductase expression in the neonatal rat inner medulla. J Clin Invest 90:1275-1283.
32. Simon EA, Cook S, Davisson MT, D'Eustachio P, Guay-Woodford LM. 1994. The mouse congenital polycystic kidney (cpk) locus maps within 1.3 cM of the chromosome 12 marker D12Nyu2. Genomics 21:415-418.
33. Spitzer A, Schwartz GJ. 1992. The kidney during development. In: Handbook of physiology. New York: American Physiological Society and Oxford University Press. p 474-544.
34. Taub M, Laurie GW, Martin GR, Kleinmen HK. 1990. Altered basement membrane protein biosynthesis by primary cultures of cpk / cpk mouse kidney. Kidney Int 37:1090-1097.
35. Terashima Y, Kondo K, Mizuno Y Iwasaki Y, Oiso Y. 1998. Influence of acute elevation of plasma AVP level on rat vasopressin V2 receptor and aquaporin-2 mRNA expression. J Mol Endocrinol 20:281-285.
36. Yamaguchi T, Nagao S, Kasahara M, Takahashi H, Grantham JJ. 1997. Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am J Kidney Dis 30:703-709.
37. Yamamoto T, Sasaki S, Fushimi K, Ishibashi K, Yaoita E, Kawasaki K, Fujinaka H, Marumo F, Kihara I. 1997. Expression of AQP family in rat kidneys during development and maturation. Am J Physiol 272:F198-204.
38. Yamamura Y, Ogawa H, Yamashita H, Chihara T, Miyamoto H, Nakamura S, Onogawa T, Yamashita T, Hosokawa T, Mori T, Tominaga M, Yabuuchi Y. 1992. Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. Br J Pharmacol 105:787-791.
39. Yasui M, Marples D, Belusa R, Eklof AC, Celsi G, Nielsen S, Aperia A. 1996. Development of urinary concentrating capacity: role of aquaporin-2. Am J Physiol 271:F461-468.